David E. Arterburn MD, MPH, FACP

David Arterburn, MD, MPH is a general internist and a health services researcher who holds positions as an Associate Investigator at Group Health Research Institute and as an Affiliate Associate Professor with the University of Washington School of Medicine in Seattle. He is a graduate of the University of Kentucky’s College of Medicine, and he completed his residency and chief residency in Internal Medicine at the University of Texas Health Science Center at San Antonio. He also holds a Master of Public Health from the University of Washington. Dr. Arterburn has been awarded numerous federal and foundation grants and has published more than 50 scientific manuscripts in the areas of obesity and shared decision making. His current research covers a broad range, including comparative effectiveness of weight management interventions, pharmacoepidemiology, pharmacogenetics, bariatric surgery, and shared decision making related to elective surgery. Dr. Arterburn’s prior research in the area of obesity pharmacotherapy has had a significant impact on clinical practice guidelines issued by the VA, the U.S. Preventive Services Task Force, the Agency for Healthcare Research and Quality, and the American College of Physicians. Dr. Arterburn is the past Chair of the Adult Obesity Measurement Advisory Panel for the National Committee on Quality Assurance, the Founding Chair of the Health Services Research Section of The Obesity Society, and past Chair of the HMORN Obesity Research Network. In 2013, he Co-Chaired the National Institutes of Health's workshop on the Long-Term Outcomes of Bariatric Surgery. He currently serves as Medical Editor for the Informed Medical Decisions Foundation, and he is a standing member of the Group Health Human Subjects Review Committee.